There are two main endocannabinoid receptors: CB1 receptors, which are mostly found in the central nervous system CB2 receptors, which are mostly found in your peripheral nervous system ...

The move for Embark Biotech comes shortly after Novo Nordisk agreed to acquire Inversago and its peripherally acting CB1 receptor (CB1r) blocker therapies for up to $1.075 billion. The lead ...

The cannabis sector remains one of the fastest-growing industries globally, with a market size valued at nearly $50 billion in 2024. While this industry is expected to surpass the $170 billion mark by ...

Inversago is working on peripherally acting CB1 receptor blocker therapies, with the receptor thought to play a role in appetite, and Embark is focused on a potential drug to boost calorie ...

A study conducted at Namseoul University in South Korea has found that tetrahydrocannabivarin (THCV), a non-psychoactive cannabinoid found in marijuana, could offer therapeutic benefits for those with ...

People eat CBD gummies for sleep, anxiety, stress, and relaxation all the time. These edible treats come in lots of delicious ...

Department of Medical and Digital Engineering, College of Engineering, Hanyang University, Seoul 04763, Republic of Korea ...

SAN DIEGO, April 29, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) ("Skye”), a clinical-stage biotechnology ...

Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on unlocking new ...

Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS), a clinical-stage biopharmaceutical company specializing in the development of treatments for brain and peripheral diseases involving the CB1 receptor, ...